The Movement Lost Its Newsroom the Same Week Washington Declared It Finished

Shreeta Waldon runs the Kentucky Harm Reduction Coalition. This year her team handed out 48,465 fentanyl test strips — paper cards that change color if the drugs someone is about to use contain something that can kill them in minutes. It costs about a dollar a strip. Then the federal government told her the $400,000 grant funding that work was gone. “It doesn’t make sense,” she told CBS News, “that one day something is an evidence-based protocol, and you decide, because of political climate, it is no longer evidence-based.”

That was August 8. Three days later, Filter — the harm reduction newsroom that would have chased that story into every state like Waldon’s — announced it was shutting down. Editor Will Godfrey wrote that after eight years, Filter “was unable to survive an increasingly difficult funding landscape.” One day after that, HHS unveiled a national framework built around a phrase meant to replace “harm reduction” in federal vocabulary: “treatment first.”

A movement doesn’t usually lose its money, its philosophy, and its press corps in a five-day span. This time it did — and the three losses are the same story told three times.

What actually changed, and why it matters that it’s boring

Start with the part that sounds like paperwork, because the paperwork is the whole mechanism. On July 29, 2025, SAMHSA sent grantees a Dear Colleague letter announcing a shift “away from harm reduction and practices that facilitate illicit drug use,” tied to an executive order on “Ending Crime and Disorder on America’s Streets.” The FY2026 Grant Application Guide made it concrete: grantees can no longer purchase or distribute fentanyl test strips, or xylazine or medetomidine test strips, for use by people who are currently using drugs. Professional and clinical drug-checking is still allowed. Handing a strip to the person standing in front of you is not.

If you’ve never used one, here’s the plain version: a fentanyl test strip is dipped in a small amount of dissolved drug residue and shows one line or two, the same technology as a pregnancy test, repurposed to answer the single most consequential question a person can ask before they use — is there something in this that will kill me tonight. Xylazine and, increasingly, medetomidine strips do the same for the animal tranquilizers now routinely showing up in street opioids, adulterants that don’t respond to naloxone and that turn an overdose into a wound-care crisis even when it isn’t fatal. None of these tools tell anyone how to use drugs. They tell people what they’re about to use. That distinction is the entire disagreement, and Waldon’s coalition is not the only casualty of it — Fyrebird Recovery, a smaller peer-support organization, lost a $4,000 grant in the same sweep. “How far will it go,” founder A’zhane Powell asked, “until we’re back to square one again?”

Maritza Perez Medina, director of federal policy at the Drug Policy Alliance, put the mechanism in one sentence: the change strips “people of the tools we know save lives,” and if the goal is genuinely to route more people into treatment, gutting “all the things that work” first means “when people seek help, they won’t find any doors open.” That is the layman’s version of a real policy tension worth sitting with, not waving away: nobody serious argues test strips alone end an overdose crisis. The argument is about what happens to the person who is still using in the gap between today and the day treatment is actually available to them — a gap that, per the CDC’s own numbers, is currently killing roughly 68,000 Americans a year, a real and welcome decline from 2023’s 111,000, but not zero, and not a population that stops needing information just because the word “harm reduction” has become politically toxic.

The toolkit that names the alternative — and what it leaves out

The August 12 HHS release gave that alternative a name. “Treatment first” replaces the Biden-era “housing first” framework with one that leads on abstinence, faith-based programming, and structure — daily schedules, employment, sleep — before unconditional housing. HHS Secretary Robert F. Kennedy Jr. framed it as a moral clarification: “Treatment must come first. Recovery begins when we connect people with effective care, not leave them trapped in addiction and homelessness.” HUD Secretary Scott Turner made the housing argument explicit: “I have met men and women whose lives have been transformed by treatment and recovery. Housing is essential, but housing alone is not enough.”

“Treatment first” replaces the Biden-era “housing first” framework with one that leads on abstinence, faith-based programming, and structure — daily schedules, employment, sleep — before unconditional housing.

Here is the detail that should worry anyone who actually treats opioid use disorder for a living, and it is not a rhetorical objection — it’s a clinical one. Buprenorphine and methadone, the two medications with the deepest evidence base for keeping people with opioid use disorder alive, get only passing mention in the new toolkit. Contingency management — cash or gift-card incentives for verified abstinence — survives, because it fits a behavioral-reward story administration officials find intuitive. Medication that manages a chronic brain-based dependency doesn’t fit that story as cleanly, so it gets a sentence instead of a section. A framework that leads with “treatment first” while soft-pedaling the treatments with the strongest mortality data isn’t rejecting harm reduction in favor of something more rigorous. It’s rejecting the parts of both harm reduction and medicine that don’t flatter a specific narrative about willpower and structure.

We have watched a government decide that a cheap thing which keeps people alive sends the wrong message before. In November 1988, over the objection of nearly every public health official who testified, Congress passed the Health Omnibus Programs Extension Act, which barred federal funds from paying for the needle and syringe exchanges that were, at that moment, the only intervention slowing HIV transmission among people who inject drugs. The ban held for 21 years, through a period when the CDC itself was quietly funding research proving exchanges worked while Congress refused to let a single federal dollar pay for one. Nobody has an exact count of how many HIV infections that gap produced, because that is what a funding ban does — it doesn’t just stop the intervention, it stops the accounting. The pattern is not subtle: reframe the tool that keeps people alive as the thing enabling their death, and the body count becomes someone else’s problem to document, assuming anyone is still funded to try.

The reporter who would have covered this from inside it

This is where Filter’s closure stops being a footnote to the policy story and becomes the story. One of the outlet’s last published pieces, on August 12 — the same day as the HHS toolkit — was deputy editor Kastalia Medrano’s own account of using methamphetamine daily for three or four years. She didn’t write it as a cautionary tale. “I used meth for three or four years, every day,” she wrote, “and while it made a lot of things in my life harder I’m not sure how else I could have managed.” She met her husband through meth use; it “kept him alive for the decade or so when the rest of the world was trying to kill him.”

If you have ever used a drug to get through a shift, a night on the street, a stretch of time nobody was checking on you, you already know the thing Medrano is naming and most coverage of addiction never says out loud: use is frequently not the crisis, it’s the coping mechanism holding the actual crisis — poverty, homelessness, violence, exhaustion — at arm’s length. Medrano’s argument is that harm reduction infrastructure was built around opioid users and grafted onto stimulant users afterward, missing that meth’s context — sex work, night shifts, survival on the street — needs different tools than a gift card for a clean urine screen. That is a genuinely contrarian, arguable position, not a feel-good redemption arc, and it is exactly the kind of first-person reporting a treatment-first framework has no mechanism to produce, because it starts from the assumption that the person using is already off-script.

Board member Morgan Godvin, who has her own history of drug use, put what Filter did in one line: it “treated the experiences that had so often been used to diminish people like me as expertise — it turned isolation into community.” Board member Diane Goldstein: “I believe people who use drugs deserve to be seen with dignity, not judged from a distance. Watching it close feels like losing a piece of my own family.” Godfrey’s statement said the archive will stay online for years. The reporting stops.

Watching it close feels like losing a piece of my own family.” Godfrey’s statement said the archive will stay online for years.

What’s still yours tonight

None of this touches naloxone, and that distinction matters enough to say plainly: federal naloxone funding was not part of this month’s cuts, and it remains legal, available, and free through most state distribution programs regardless of what SAMHSA’s grant guide says about test strips. The methadone reforms STAT documented three-quarters of clinics adopting — more take-home doses, counseling made optional rather than mandatory — are still in effect and unrelated to this policy shift. If you are the person this article is actually for, not the provider reading it for a Monday staff meeting: the tools that get you through tonight didn’t disappear this month. What disappeared is a chunk of the infrastructure — the strips, the newsroom that covered the strips — that was supposed to make tomorrow more survivable than today.

Filter’s website will sit there, archived, for years, a record of eight years of a movement being taken seriously by people who’d actually lived it. What it can’t do anymore is send Kastalia Medrano back out to ask the next Shreeta Waldon what just got cut, and why, and who’s going to feel it first. That job doesn’t disappear along with the newsroom. It just doesn’t have anyone assigned to it right now.